- Home
- VNDA vs KNOP Comparison
VNDA vs KNOP Comparison
Compare VNDA & KNOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- KNOP
- Stock Information
- Founded
- VNDA 2002
- KNOP 2013
- Country
- VNDA United States
- KNOP United Kingdom
- Employees
- VNDA N/A
- KNOP N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- KNOP Marine Transportation
- Sector
- VNDA Health Care
- KNOP Consumer Discretionary
- Exchange
- VNDA Nasdaq
- KNOP Nasdaq
- Market Cap
- VNDA 237.9M
- KNOP 254.2M
- IPO Year
- VNDA 2006
- KNOP 2013
- Fundamental
- Price
- VNDA $4.34
- KNOP $6.38
- Analyst Decision
- VNDA Strong Buy
- KNOP
- Analyst Count
- VNDA 3
- KNOP 0
- Target Price
- VNDA $15.33
- KNOP N/A
- AVG Volume (30 Days)
- VNDA 519.0K
- KNOP 59.6K
- Earning Date
- VNDA 05-07-2025
- KNOP 05-20-2025
- Dividend Yield
- VNDA N/A
- KNOP 1.63%
- EPS Growth
- VNDA N/A
- KNOP N/A
- EPS
- VNDA N/A
- KNOP 0.19
- Revenue
- VNDA $201,351,000.00
- KNOP $320,026,000.00
- Revenue This Year
- VNDA $16.86
- KNOP $5.04
- Revenue Next Year
- VNDA $39.78
- KNOP $1.00
- P/E Ratio
- VNDA N/A
- KNOP $33.84
- Revenue Growth
- VNDA 13.37
- KNOP 8.76
- 52 Week Low
- VNDA $3.81
- KNOP $5.28
- 52 Week High
- VNDA $6.75
- KNOP $9.11
- Technical
- Relative Strength Index (RSI)
- VNDA 51.79
- KNOP 46.73
- Support Level
- VNDA $4.17
- KNOP $6.21
- Resistance Level
- VNDA $4.41
- KNOP $6.48
- Average True Range (ATR)
- VNDA 0.16
- KNOP 0.21
- MACD
- VNDA 0.03
- KNOP -0.04
- Stochastic Oscillator
- VNDA 73.61
- KNOP 25.76
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About KNOP KNOT Offshore Partners LP Common Units representing Limited Partner Interests
KNOT Offshore Partners LP owns, operates, and shuttles tankers under long-term charters in the North Sea and Brazil. The company provides crude oil loading, transportation, and storage services under time charters and bareboat charters. The Partnership is formed for acquiring ownership interests in over four shuttle tankers owned by Knutsen NYK Offshore Tankers AS (KNOT). It operates through the shuttle tanker market segment.